GEN Exclusives

More »

Jun. 15, Vol. 25, No. 12

    • Feature Articles

      • Applying Nanotech to Materials Research
      • Gail Dutton
      • Nanotech, the manipulation of individual molecules to produce materials with new and unique structural properties, is poised to become a major force in advanced materials research that will affect areas of research as diverse as drug delivery, elect ... more »
      • Can India's IT Success be Replicated in Biotech?
      • Active support from the Indian government for increased funds and infrastructure, such as biotech parks, as well as an emphasis on R&D, will help strengthen India's biotech sector in the near future, according to M.K. Bhan, M.D., secretary, ... more »
      • High Demand for Target Validation Technologies
      • The various methods used in target validation were the focus of discussion earlier this month at two separate meetings held in Boston and a third meeting in Singapore. The Boston meetings included the "IBC USA Early Efficacy Assessment Meeting& ... more »
      • PCR Gains Momentum with New Applications
      • PCR turns twenty this year, dating from its invention in 1985 by Kary B. Mullis. Since then, applications and adaptations of PCR have proliferated. The advent of real-time PCR couples a modified thermocycler with real-time kinetics, for a highly acc ... more »
      • Research Options for Structural Proteomics
      • Gail Dutton
      • Not so long ago, structural proteomics research was divided into two distinct campsx-ray crystallography and NMR spectroscopy. X-ray crystallography remains the gold standard for structural determination, but NMR capabilities are proving their value ... more »
      • Using Complexity to Enhance Drug Discovery
      • Participants in Cambridge Healthtech's conference, "Systems Biology: Validation of Multi-Variate Biology," held recently in San Francisco, described multiple approaches to putting biology back into drug discovery and development as wel ... more »
    • FDA News and Analysis

      • FDA Needs to Balance Risks and Benefits for Patients
      • The Food and Drug Administration, considered to be the most trusted federal agency, is under attack for trying to do what it does bestprotect the publics health by approving therapeutics that are both safe and effective. Unlike the generic drug sca ... more »
    • Tutorials

      • Evaluation of the CellFerm-Pro STBR System
      • Improved process development technology can positively impact process development outcomes in three ways. First, process development technology with increased throughput allows the evaluation of more process conditions, increasing the probability of ... more »
      • Miniaturized Filtration Assay for Discovery
      • A major focus in drug discovery involves the identification of compounds that reduce or modulate biological processes by altering the activity of cellular receptors or signal transduction components such as kinases. Located in the cell membrane, the ... more »
      • Taking Computational Biology to the Bench
      • Discovery is challenged by constantly changing data requirements and increasing analytics complexity. More and more labs need flexible informatics with less programming. New informatics software, called experiment design automation (XDA), can help l ... more »


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »